FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336974238> ?p ?o ?g. }

• W2336974238 abstract "Background: Multikinase inhibitors (MKI) inter- fere effectively at different levels of the neovascu- larisation cascade. Early clinical and experimental data suggest that MKIs represent a promising novel approach for the treatment of neovascular age-related macular degeneration (AMD). Howev- er, so far little is known about the biocompatibil- ity of MKIs regarding human ocular cells. This in vitro study investigates and compares the bio- compatibility of three MKIs, axitinib, pazopanib, and sorafenib regarding ocular cells of the anteri- or and posterior segments, as well as organ-cul- tured donor corneas. Methods: Primary human optic nervehead astro- cytes (ONHA), trabecular meshwork cells (TMC), and retinal pigment epithelium (RPE), human corneal endothelial and lens epithelial cells (CEC and LEC) were treated with different concentra- tions of axitinib, pazopanib, or sorafenib (0.1 to 100µg/mL). To simulate oxidative stress, the cells were additionally co-incubated with 400 µM hy- drogen peroxide. Induction of cell death and cel- lular viability were examined by live-dead assay and tetrazolium dye reduction assay (MTT). In ad- dition, the influence of the three substances on human corneal endothelium was evaluated in se- ropositive donor corneas in organ culture by phase contrast microscopy. Results: Up to a concentration of 7.5 mg/mL of the" @default.
• W2336974238 created "2016-06-24" @default.
• W2336974238 creator A5024110425 @default.
• W2336974238 creator A5026498573 @default.
• W2336974238 creator A5037588636 @default.
• W2336974238 creator A5038996603 @default.
• W2336974238 creator A5041844684 @default.
• W2336974238 creator A5046525683 @default.
• W2336974238 creator A5051825660 @default.
• W2336974238 creator A5053570514 @default.
• W2336974238 creator A5054706794 @default.
• W2336974238 creator A5090267247 @default.
• W2336974238 date "2013-01-01" @default.
• W2336974238 modified "2023-09-26" @default.
• W2336974238 title "Multikinase-Inhibitoren als therapeutischer Ansatz bei neovaskulärer AMD: In-vitro-Evaluation der Sicherheit von Axitinib, Pazopanib und Sorafenib zur intraokularen Anwendung Multikinase Inhibitors as a New Approach in Neovascular Age-Related Macular Degeneration (AMD) Treatment: In Vitro Safety Evaluations of Axitinib, Pazopanib and Sorafenib for Intraocular Use" @default.
• W2336974238 cites W1802218256 @default.
• W2336974238 cites W1889509830 @default.
• W2336974238 cites W1972903016 @default.
• W2336974238 cites W1984451785 @default.
• W2336974238 cites W1998290564 @default.
• W2336974238 cites W2023047656 @default.
• W2336974238 cites W2032951723 @default.
• W2336974238 cites W2034106071 @default.
• W2336974238 cites W2034630124 @default.
• W2336974238 cites W2042464967 @default.
• W2336974238 cites W2051856235 @default.
• W2336974238 cites W2060628375 @default.
• W2336974238 cites W2070396671 @default.
• W2336974238 cites W2078317173 @default.
• W2336974238 cites W2117150876 @default.
• W2336974238 cites W2124415048 @default.
• W2336974238 cites W2139231040 @default.
• W2336974238 cites W2163254171 @default.
• W2336974238 cites W2915852396 @default.
• W2336974238 cites W3350394 @default.
• W2336974238 hasPublicationYear "2013" @default.
• W2336974238 type Work @default.
• W2336974238 sameAs 2336974238 @default.
• W2336974238 citedByCount "0" @default.
• W2336974238 crossrefType "journal-article" @default.
• W2336974238 hasAuthorship W2336974238A5024110425 @default.
• W2336974238 hasAuthorship W2336974238A5026498573 @default.
• W2336974238 hasAuthorship W2336974238A5037588636 @default.
• W2336974238 hasAuthorship W2336974238A5038996603 @default.
• W2336974238 hasAuthorship W2336974238A5041844684 @default.
• W2336974238 hasAuthorship W2336974238A5046525683 @default.
• W2336974238 hasAuthorship W2336974238A5051825660 @default.
• W2336974238 hasAuthorship W2336974238A5053570514 @default.
• W2336974238 hasAuthorship W2336974238A5054706794 @default.
• W2336974238 hasAuthorship W2336974238A5090267247 @default.
• W2336974238 hasConcept C142724271 @default.
• W2336974238 hasConcept C185592680 @default.
• W2336974238 hasConcept C190283241 @default.
• W2336974238 hasConcept C202751555 @default.
• W2336974238 hasConcept C2776539811 @default.
• W2336974238 hasConcept C2777472916 @default.
• W2336974238 hasConcept C2778019345 @default.
• W2336974238 hasConcept C2778439243 @default.
• W2336974238 hasConcept C2778695046 @default.
• W2336974238 hasConcept C2779490328 @default.
• W2336974238 hasConcept C31573885 @default.
• W2336974238 hasConcept C502942594 @default.
• W2336974238 hasConcept C55493867 @default.
• W2336974238 hasConcept C71924100 @default.
• W2336974238 hasConcept C98274493 @default.
• W2336974238 hasConceptScore W2336974238C142724271 @default.
• W2336974238 hasConceptScore W2336974238C185592680 @default.
• W2336974238 hasConceptScore W2336974238C190283241 @default.
• W2336974238 hasConceptScore W2336974238C202751555 @default.
• W2336974238 hasConceptScore W2336974238C2776539811 @default.
• W2336974238 hasConceptScore W2336974238C2777472916 @default.
• W2336974238 hasConceptScore W2336974238C2778019345 @default.
• W2336974238 hasConceptScore W2336974238C2778439243 @default.
• W2336974238 hasConceptScore W2336974238C2778695046 @default.
• W2336974238 hasConceptScore W2336974238C2779490328 @default.
• W2336974238 hasConceptScore W2336974238C31573885 @default.
• W2336974238 hasConceptScore W2336974238C502942594 @default.
• W2336974238 hasConceptScore W2336974238C55493867 @default.
• W2336974238 hasConceptScore W2336974238C71924100 @default.
• W2336974238 hasConceptScore W2336974238C98274493 @default.
• W2336974238 hasLocation W23369742381 @default.
• W2336974238 hasOpenAccess W2336974238 @default.
• W2336974238 hasPrimaryLocation W23369742381 @default.
• W2336974238 hasRelatedWork W1967990316 @default.
• W2336974238 hasRelatedWork W2035375375 @default.
• W2336974238 hasRelatedWork W2035425473 @default.
• W2336974238 hasRelatedWork W2042186177 @default.
• W2336974238 hasRelatedWork W2062098889 @default.
• W2336974238 hasRelatedWork W2067938911 @default.
• W2336974238 hasRelatedWork W2093208593 @default.
• W2336974238 hasRelatedWork W2117150876 @default.
• W2336974238 hasRelatedWork W2123544284 @default.
• W2336974238 hasRelatedWork W2130347338 @default.
• W2336974238 hasRelatedWork W2159764938 @default.
• W2336974238 hasRelatedWork W2161582086 @default.
• W2336974238 hasRelatedWork W2284785638 @default.
• W2336974238 hasRelatedWork W2993988756 @default.
• W2336974238 hasRelatedWork W3009641607 @default.
• W2336974238 hasRelatedWork W3049539477 @default.
• W2336974238 hasRelatedWork W3156844196 @default.

• next